Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19.

Saved in:
Bibliographic Details
Title: Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19.
Authors: Contreras Nieves M; Nephrology, Department of Medicine, Stanford University, Stanford, California. Electronic address: mcontre@stanford.edu., Anand S; Nephrology, Department of Medicine, Stanford University, Stanford, California., Thomas IC; Nephrology, Department of Medicine, Stanford University, Stanford, California; Geriatric Research and Education Clinical Center, Veterans Affairs Palo Alto, Palo Alto, California., Geldsetzer P; Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California., Fung E; Nephrology, Department of Medicine, Stanford University, Stanford, California., Tamura MK; Nephrology, Department of Medicine, Stanford University, Stanford, California; Geriatric Research and Education Clinical Center, Veterans Affairs Palo Alto, Palo Alto, California., Montez-Rath ME; Nephrology, Department of Medicine, Stanford University, Stanford, California.
Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2025 Aug; Vol. 86 (2), pp. 202-211.e1. Date of Electronic Publication: 2025 Apr 07.
Publication Type: Journal Article
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6838 (Electronic) Linking ISSN: 02726386 NLM ISO Abbreviation: Am J Kidney Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first